ARBUTUS BIOPHARMA CORP NPV revenue breakdown overview

ARBUTUS BIOPHARMA CORP NPV revenue for the last year amounted to 18.14 M USD, the most of which — 18.14 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 39.02 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ARBUTUS BIOPHARMA CORP NPV 18.14 M USD, and the year before that — 39.02 M USD.